Bristlecone Advisors LLC Cuts Holdings in SPDR S&P Biotech ETF $XBI

Bristlecone Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,453 shares of the exchange traded fund’s stock after selling 7,447 shares during the period. Bristlecone Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,364,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. DHJJ Financial Advisors Ltd. purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $25,000. Garrison Bradford & Associates Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $39,000. Quaker Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 53,536 shares in the last quarter. Compass Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.4%

Shares of XBI stock opened at $112.00 on Wednesday. The company has a market cap of $6.87 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The stock has a 50 day simple moving average of $98.97 and a 200-day simple moving average of $88.51. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $112.43.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.